Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
CE

C. Todd Eary — 6 Patents

ABArray Biopharma: 4 patents #146 of 335Top 45%
INIntermune: 2 patents #31 of 57Top 55%
VPVentirx Pharmaceuticals: 2 patents #9 of 18Top 50%
Boulder, CO: #1,132 of 5,018 inventorsTop 25%
Colorado: #7,724 of 40,980 inventorsTop 20%
Overall (All Time): #779,687 of 4,157,543Top 20%
6 Patents All Time
C. Todd Eary has been granted 6 US patents while listed as an inventor at Array Biopharma. The first was granted in 2010 and the most recent in October 2017. C. Todd Eary ranks #779,687 of 4,157,543 US inventors in our database (top 18.8%). Patent records list C. Todd Eary in Boulder, CO, US.

Issued Patents All Time

Showing 1–6 of 6 patents

Patent #TitleCo-InventorsDateApprox Value ⓘ
9790206 Intermediates for use in the preparation of indazole derivatives and processes for the preparation thereof Bruno P. Hache, Derrick Juengst, Stacey Spencer, Peter J. Stengel, Daniel J. Watson 2017-10-17 $7,871,000
9242964 Substituted benzoazepines as toll-like receptor modulators James Jeffry Howbert, Gregory Dietsch, Robert Hershberg, Laurence E. Burgess, George A. Doherty +2 more 2016-01-26 $4,860,000
8524702 Substituted benzoazepines as toll-like receptor modulators James Jeffry Howbert, Gregory Dietsch, Robert Hershberg, Laurence E. Burgess, George A. Doherty +2 more 2013-09-03 $8,130,000
8299021 Macrocyclic inhibitors of hepatitis C virus replication Lawrence M. Blatt, Scott D. Seiwert, Steven W. Andrews, Pierre Martin, Andreas Schumacher +10 more 2012-10-30
8153622 8-substituted benzoazepines as toll-like receptor modulators George A. Doherty, Robert D. Groneberg, Zachary Jones 2012-04-10 $4,077,000
7829665 Macrocyclic inhibitors of hepatitis C virus replication Lawrence M. Blatt, Scott D. Seiwert, Steven W. Andrews, Pierre Martin, Andreas Schumacher +10 more 2010-11-09 $24,983,000